Rocket Lab Corporation $RKLB Shares Bought by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. boosted its stake in shares of Rocket Lab Corporation (NASDAQ:RKLB) by 43.6% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 2,235,469 shares of the rocket manufacturer’s stock after purchasing an additional 678,342 shares during the period. Sumitomo Mitsui Trust Group Inc. owned approximately 0.37% of Rocket Lab worth $155,767,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. Hilton Head Capital Partners LLC lifted its holdings in shares of Rocket Lab by 3,590.0% in the 3rd quarter. Hilton Head Capital Partners LLC now owns 369 shares of the rocket manufacturer’s stock valued at $26,000 after buying an additional 359 shares during the period. Meeder Asset Management Inc. acquired a new stake in Rocket Lab during the second quarter worth about $30,000. Highland Investment Advisors LLC acquired a new stake in Rocket Lab during the second quarter worth about $30,000. NBH Bank acquired a new stake in Rocket Lab during the second quarter worth about $30,000. Finally, Cherry Tree Wealth Management LLC purchased a new position in Rocket Lab during the second quarter valued at approximately $32,000. Hedge funds and other institutional investors own 71.78% of the company’s stock.

Rocket Lab Price Performance

Shares of Rocket Lab stock opened at $54.73 on Monday. The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01. Rocket Lab Corporation has a twelve month low of $37.57 and a twelve month high of $151.00. The business has a 50-day moving average price of $64.23 and a 200 day moving average price of $79.93. The firm has a market cap of $32.75 billion, a PE ratio of -202.70 and a beta of 3.15.

Rocket Lab (NASDAQ:RKLB) last released its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). The business had revenue of $234.07 million during the quarter, compared to analyst estimates of $231.62 million. Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. Sell-side analysts predict that Rocket Lab Corporation will post -0.20 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have issued reports on RKLB shares. Raymond James Financial assumed coverage on Rocket Lab in a report on Friday, September 11th. They issued an “outperform” rating and a $80.00 price target for the company. KGI Securities raised shares of Rocket Lab from a “neutral” rating to an “outperform” rating and set a $107.00 price objective on the stock in a research note on Monday, July 27th. Cantor Fitzgerald reaffirmed a “mixed” rating and set a $122.00 target price on shares of Rocket Lab in a report on Thursday, October 15th. Citigroup reiterated a “market outperform” rating on shares of Rocket Lab in a research note on Friday, October 16th. Finally, Barclays began coverage on shares of Rocket Lab in a report on Friday, October 9th. They set an “overweight” rating and a $85.00 price target on the stock. Three analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Rocket Lab currently has an average rating of “Moderate Buy” and an average price target of $102.05.

Insiders Place Their Bets

In other news, insider Marvin Clevenger sold 15,051 shares of the company’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $1,048,001.13. Following the completion of the transaction, the insider directly owned 458,924 shares of the company’s stock, valued at $31,954,878.12. This represents a 3.18% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Agostino Ricupati sold 669 shares of the stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $69.63, for a total value of $46,582.47. Following the transaction, the chief accounting officer owned 26,863 shares in the company, valued at $1,870,470.69. This trade represents a 2.43% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 400,749 shares of company stock valued at $26,964,474. 8.40% of the stock is owned by insiders.

Rocket Lab News Roundup

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab continues to make operational progress: Neutron’s second stage and thrust module have reached Wallops Island, Virginia, for ground testing, while the company is preparing to ship its 100th Electron rocket. These milestones suggest development is advancing despite the launch delay. RKLB Stock Tests Bulls’ Patience
• Positive Sentiment: Analysts and bullish investors continue to point to Rocket Lab’s expanding business, including strong revenue growth, a reported $2.36 billion backlog, NASA-related opportunities, Iridium work and Mynaric exposure. Some forecasts argue that a successful Neutron milestone could eventually prompt a significant re-rating toward $100. Price Prediction: Rocket Lab Stock Will Hit $100
• Neutral Sentiment: The bullish investment thesis remains intact for some investors, but the Neutron delay changes the expected timing of revenue, launches and potential profitability. Rocket Lab’s substantial cash position and low leverage provide flexibility, though its high-growth valuation leaves the stock sensitive to schedule changes. The Neutron Delay Changes the Timeline, Not the Thesis
• Negative Sentiment: Investors are concerned that manufacturing defects in Neutron’s carbon-fiber structures—likened to trapped bubbles in a layered cake—contributed to the schedule slip. The delay increases execution risk and could lead to additional spending or dilution if development takes longer than expected. Rocket Lab Stock Lost Its Launch Date
• Negative Sentiment: An analyst fair-value estimate was trimmed from approximately $105.05 to $102.15, reflecting lower near-term expectations and greater execution risk following the Neutron delay. With Rocket Lab still unprofitable, investors are placing greater emphasis on delivery milestones rather than current earnings. Rocket Lab Fair Value Trim After Neutron Delay

Rocket Lab Company Profile

Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.

Rocket Lab’s launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.

Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.